Potential role of endothelin in hypertension. Controversy on endothelin in hypertension.
- 1 June 1993
- journal article
- review article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 21 (6_pt_1), 752-757
- https://doi.org/10.1161/01.hyp.21.6.752
Abstract
No abstract availableThis publication has 55 references indexed in Scilit:
- Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptorLife Sciences, 1992
- Pharmacologic Characterization of an EndothelinA (ETA) Receptor Antagonist in Conscious RatsJournal of Cardiovascular Pharmacology, 1992
- Different distribution of endothelin receptor subtypes in pulmonary tissues revealed by the novel selective ligands BQ-123 and [Ala1,3,11,15]ET-1Biochemical and Biophysical Research Communications, 1992
- Phosphoramidon inhibits the intracellular conversion of big endothelin-1 to endothelin-1 in cultured endothelial cellsBiochemical and Biophysical Research Communications, 1991
- Phosphoramidon Blocks the Pressor Activity of Big Endothelin[1–39] and Lowers Blood Pressure in Spontaneously Hypertensive RatsJournal of Cardiovascular Pharmacology, 1991
- Endothelins come home to roostNature, 1990
- Characterization of endothelin converting enzyme activities in soluble fraction of bovine cultured endothelial cellsBiochemical and Biophysical Research Communications, 1990
- Evidence for endothelin-1 release from resistance vessels of rats in response to hypoxiaBiochemical and Biophysical Research Communications, 1990
- Ischaemia causes externalization of endothelin-1 binding sites in rat cardiac membranesBiochemical and Biophysical Research Communications, 1989
- Endothelin enhances adrenergic vasoconstriction in perfused rat mesenteric arteriesBiochemical and Biophysical Research Communications, 1989